Validating the Interval to Biochemical Failure for the Identification of Potentially Lethal Prostate Cancer

A Nomogram Predicting 5-year Probability of Cause Specific Survival from Biochemical Failure following Radiotherapy

(2011) M.K. Buyyounouski et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

The effect of salvage therapy on survival in a longitudinal study with treatment by indication

(2010) Edward H. Kennedy et al.   STATISTICS IN MEDICINE

Postradiotherapy 2-Year Prostate-Specific Antigen Nadir as a Predictor of Long-Term Prostate Cancer Mortality

(2009) Michael J. Zelefsky et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era

(2009) Andrew J. Stephenson et al.   JOURNAL OF CLINICAL ONCOLOGY

Current Applications for Prostate-Specific Antigen Doubling Time

(2008) Michelle L. Ramírez et al.   EUROPEAN UROLOGY

Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling Time

(2008) Philip M. Arlen et al.   JOURNAL OF UROLOGY

Percentage of Biopsy Cores Positive for Malignancy and Biochemical Failure Following Prostate Cancer Radiotherapy in 3,264 Men: Statistical Significance Without Predictive Performance

(2007) Scott G. Williams et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Interval to Biochemical Failure Highly Prognostic for Distant Metastasis and Prostate Cancer-Specific Mortality After Radiotherapy

(2007) Mark K. Buyyounouski et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS